Cerebyx (fosphenytoin sodium)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 PRECAUTIONS General: (phenytoin associated) Plasma concentrations of phenytoin sustained above the optimal range may...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts